查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1555491

围产期感染市场，按感染、诊断、治疗、给药途径、最终用户和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Perinatal Infections Market, By Infection, By Diagnosis, By Treatment, By Route of Administration, By End User, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 260 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告要点

2023 年围产期感染市场规模为 41.252 亿美元，2024 年至 2032 年复合年增长率为 6.00%。

围产期感染市场-市场动态

围产期感染盛行率不断上升推动市场成长

由于全球产前感染盛行率不断上升，全球围产期感染市场正在扩大。母亲和婴儿都受到这些感染的严重威胁，凸显了改善预防、诊断和治疗方法的必要性。在整个怀孕期间或临产期间的任何时候，母亲及其未出生孩子的健康都因围产期感染而处于危险之中。人类免疫缺乏病毒 (HIV)、B型肝炎、梅毒、B 型链球菌 (GBS) 和披衣菌是影响婴儿的常见疾病。严重的后果包括早产、低出生体重、新生儿败血症、先天性畸形以及这些感染可能导致母亲发病和死亡。此外，由于多种原因，围产期感染的频率正在上升。未确诊或未治疗的感染是由于某些地区无法获得足够的产前护理和医疗资源稀缺所造成的。常规产前保健就诊对于及早筛检和识别围产期感染至关重要。必须透过预防和教育措施来改变这些习惯。

围产期感染市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 6.00% 左右的复合年增长率成长

根据感染细分，人类免疫缺陷病毒类别预计将在 2023 年显示最大的市场份额

从诊断性细分来看，2023年孕产妇检测类别为主导细分市场

根据治疗细分，抗生素类别是 2023 年的主要感染

依给药途径细分，2023年註射剂类为主导细分市场

按地区划分，北美是 2023 年的主要收入来源

围产期感染市场-細項分析：

全球围产期感染市场根据感染、诊断、治疗、给药途径、最终用户和地区进行细分。

根据诊断，市场分为三类：孕产妇检测、新生儿检测和其他。孕产妇测试类别主导市场。胚胎和胎儿几乎没有免疫力；因此，他们具有免疫力并依赖母亲。许多疾病可以在穿过胎盘后感染胎儿。孕妇经常接受诊断测试以识别任何感染，因为引起轻微疾病的细菌可能对发育中的胎儿或婴儿构成严重风险。

根据最终用户，市场分为以下几类：医院、家庭护理、专科诊所和其他。鑑于医院被认为是最安全的分娩场所，医院类别在市场上占据主导地位，并且可能在预测期内保持其主导地位。美国国家学术机构报告称，98.4% 的美国女性在医院分娩，这在市场上占了很大一部分。然而，由于越来越多的准妈妈选择在家或专业分娩中心而不是医院分娩，预计家庭护理和专科诊所在预测期内也将快速扩张。

围产期感染市场 - 地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太地区、中东和非洲地区。这些区域根据开展业务的国家进一步划分。

在预测期内，北美预计将占据全球围产期感染市场的最大份额。为了强调早期识别和治疗的价值，该地区的医疗保健产业努力提高大众对产前感染的认识。由于北美政府采取的措施（通常包括筛检计画、免疫运动和教育措施），围产期感染市场正在蓬勃发展。

此外，在医疗创新和研究的大量支出的推动下，预计亚太地区围产期感染市场预计将以全球最快的速度扩张。亚太地区进行的研究和开发的结果是出现了针对围产期感染的先进诊断工具和治疗方法。由于该地区医疗基础设施不断扩大以及对母婴健康的日益重视，亚太地区围产期感染市场持续成长。

围产期感染市场-竞争格局：

围产期感染市场的主要公司，如 Merck KGaA、Beckman Coulter Inc.、BIOMERIEUX、Bio-Rad Laboratories, Inc.、Danaher 和 Hologic Inc. 等，都专注于策略努力，包括合作伙伴关係、併购和收购。产品创新，以便在激烈的竞争环境中获得竞争优势。这些企业希望透过利用诊断突破和产品多样化来增加市场份额并满足客户和医疗保健提供者不断变化的需求。

目录

第一章：围产期感染市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 围产期感染市场片段（按感染）
    • 围产期感染诊断市场片段
    • 围产期感染治疗市场片段
    • 按给药途径分類的围产期感染市场片段
    • 最终用户围产期感染市场片段
    • 按国家/地区分類的围产期感染市场片段
    • 按地区分類的围产期感染市场片段
  • 竞争洞察

第 3 章：围产期感染主要市场趋势

  • 围产期感染市场驱动因素
    • 市场驱动因素的影响分析
  • 围产期感染市场限制
    • 市场限制影响分析
  • 围产期感染市场机会
  • 围产期感染市场未来趋势

第 4 章：围产期感染产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：围产期感染市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：围产期感染市场格局

  • 2023 年围产期感染市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：围产期感染市场 - 依感染分类

  • 概述
    • 按感染情况分類的细分市场占有率分析
    • 鉅细胞病毒感染
    • 肠病毒感染
    • 生殖器疱疹
    • 淋病
    • 人类免疫缺乏病毒
    • 其他的

第 8 章：围产期感染市场 - 按诊断

  • 概述
    • 透过诊断进行细分市场份额分析
    • 产妇测试
    • 新生儿测试
    • 其他的

第 9 章：围产期感染市场 - 按治疗分类

  • 概述
    • 按处理方式分類的细分市场占有率分析
    • 抗生素
    • 抗病毒剂
    • 抗爱滋病毒
    • 其他的

第 10 章：围产期感染市场 - 按给药途径

  • 概述
    • 按给药途径分類的细分市占率分析
    • 口服
    • 注射用
    • 其他的

第 11 章：围产期感染市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 医院
    • 居家护理
    • 专科诊所
    • 其他的

第 12 章：围产期感染市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美围产期感染主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按感染情况）
    • 北美市场规模及预测（按诊断）
    • 北美市场规模与预测（以不同处理方式）
    • 北美市场规模与预测（按管理途径）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲围产期感染主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按感染情况）
    • 欧洲市场规模和预测（透过诊断）
    • 欧洲市场规模与预测（按处理方式）
    • 欧洲市场规模与预测（按管理途径）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区围产期感染主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（依感染情形）
    • 亚太地区市场规模及预测（依诊断）
    • 亚太地区市场规模与预测（以不同处理方式）
    • 亚太地区市场规模与预测（依管理途径）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲围产期感染主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模和预测（按感染情况）
    • 拉丁美洲市场规模与预测（按诊断）
    • 拉丁美洲市场规模与预测（以不同处理方式）
    • 拉丁美洲市场规模与预测（按管理途径）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲围产期感染主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东及非洲市场规模及预测（依感染情形）
    • 中东和非洲市场规模及预测（按诊断）
    • 中东及非洲市场规模及预测（依不同处理方式）
    • 中东和非洲市场规模及预测（按管理途径）
    • 中东和非洲市场规模及预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 13 章：主要供应商分析 - 围产期感染产业

  • 竞争仪表板
  • 公司简介
    • Merck KgaA
    • Beckman Coulter Inc.
    • BIOMERIEUX
    • Bio-Rad Laboratories, Inc
    • Danaher
    • Hologic Inc.
    • Gilead Sciences, Inc.
    • Emcure Pharmaceuticals Limited.
    • Cipla Inc.
    • Hetero
    • Bausch Health Companies Inc.
    • Johnson & Johnson Private Limited
    • Mylan NV
    • Teva Pharmaceutical Industries Ltd.
    • Sanofi
    • Novartis AG
    • Sun Pharmaceutical Industries Ltd
    • Others

第 14 章：360 度分析师视角

第 15 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV3568

REPORT HIGHLIGHT

Perinatal Infections Market size was valued at USD 4,125.2 Million in 2023, expanding at a CAGR of 6.00% from 2024 to 2032.

Infections that can spread from the mother to the child during pregnancy, labor, or the initial few hours after delivery are known as perinatal infections. Due to the limited ability of neonates, particularly those born preterm, to verbalize their symptoms, even slight deviations from the norm should be interpreted as an indication of bacterial disease. Pregnancy is a common time to see diseases such as listeria, bacterial vaginosis (BV), group B streptococcus (GBS), dermatitis, herpes, vaginal yeast infections, and the flu.

Perinatal Infections Market- Market Dynamics

Growing Prevalence of Perinatal Infections to Propel Market Growth

The global market for perinatal infections is expanding as a result of the rising prevalence of prenatal infections globally. The mother and the infant are both seriously threatened by these infections, which highlights the need for improved prevention, diagnostic, and treatment methods. Any time throughout pregnancy or during labor and delivery, a mother's health and the health of her unborn child are at danger due to perinatal infections. Human immunodeficiency virus (HIV), hepatitis B, syphilis, group B streptococcus (GBS), and chlamydia are common illnesses that can affect infants. Serious consequences include preterm birth, low birth weight, neonatal sepsis, congenital abnormalities, and mother morbidity and death can result from these infections. Furthermore, the frequency of perinatal infections is rising due to a number of causes. Undiagnosed or untreated infections are a result of inadequate access to prenatal care and scarce healthcare resources in some areas. Routine prenatal care visits are crucial to screen for and identify perinatal infections early on.Prenatal infections can result from a number of high-risk behaviors, including drug addiction, unprotected sexual activity, and having several partners. It is essential to address these habits through prevention and education initiatives.

Perinatal Infections Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.00% over the forecast period (2024-2032)

Based on infection segmentation, the human immunodeficiency virus category was predicted to show maximum market share in the year 2023

Based on diagnosis segmentation, the maternal test category was the leading segment in 2023

Based on treatment segmentation, the antibiotics category was the leading infection in 2023

Based on route of administration segmentation, the parenteral category was the leading segment in 2023

On the basis of region, North America was the leading revenue generator in 2023

Perinatal Infections Market- Segmentation Analysis:

The Global Perinatal Infections Market is segmented on the basis of Infection, Diagnosis, Treatment, Route of Administration, End User and Region.

The market is divided into three categories based on diagnosis: Maternal Test, Neonatal Test, and Others. The maternal test category dominates the market. The embryo and fetus have little to no immunity; as a result, they are immune and reliant on their mother. Many illnesses can infect the fetus after crossing the placenta. Pregnant women often undergo diagnostic testing to identify any infection since germs that cause mild illnesses in them might pose a serious risk to the developing fetus or infant.

The market is divided into the following categories based on end user: Hospitals, Homecare, Specialty Clinics, and Others. The hospitals category dominates the market and is likely to maintain its dominance during the forecast period, given that hospitals are thought to be the safest places to give birth. The National Academics reports that 98.4% of American women give birth in a hospital, which is a significant portion of the market. However, because more and more expectant mothers are choosing to give birth at home or in specialized birthing centers rather than in hospitals, homecare, and specialty clinics are also expected to see rapid expansion during the forecast period.

Perinatal Infections Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Over the course of the forecast period, North America is anticipated to hold the greatest share of the global market for Perinatal Infections. In order to emphasize the value of early identification and treatment, the healthcare industry in the area has worked hard to increase public awareness of prenatal infections. The market for perinatal infections is growing favorably as a result of government measures in North America, which frequently include screening programs, immunization campaigns, and educational initiatives.

In addition, the Perinatal Infections market is anticipated to expand at the fastest rate in the world during the projected period in Asia Pacific driven by large expenditures for medical innovation and research. Advanced diagnostic tools and treatment approaches for perinatal infections have emerged as a result of research and development conducted in the Asia Pacific. The Asia Pacific market for perinatal infections is continuing to rise as a result of the region's expanding healthcare infrastructure and growing emphasis on mother and child health.

Perinatal Infections Market- Competitive Landscape:

Key companies in the perinatal infections market such as Merck KGaA, Beckman Coulter Inc., BIOMERIEUX, Bio-Rad Laboratories, Inc, Danaher, and Hologic Inc., among others, are concentrating on strategic efforts, including partnerships, mergers and acquisitions, and product innovations in order to obtain a competitive edge in a highly competitive landscape. These businesses hope to increase market share and satisfy customers' and healthcare providers' changing demands by capitalizing on diagnosis breakthroughs and diversifying their product offerings.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PERINATAL INFECTIONS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Merck KgaA
  • Beckman Coulter Inc.
  • BIOMERIEUX
  • Bio-Rad Laboratories, Inc
  • Danaher
  • Hologic Inc.
  • Gilead Sciences, Inc.
  • Emcure Pharmaceuticals Limited.
  • Cipla Inc.
  • Hetero
  • Bausch Health Companies Inc.
  • Johnson & Johnson Private Limited
  • Mylan N.V.
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi
  • Novartis AG
  • Sun Pharmaceutical Industries Ltd
  • Others

GLOBAL PERINATAL INFECTIONS MARKET, BY INFECTION- MARKET ANALYSIS, 2019 - 2032

  • Cytomegalovirus Infection
  • Enterovirus Infection
  • Genital Herpes
  • Gonorrhoea
  • Human Immunodeficiency Virus
  • Others

GLOBAL PERINATAL INFECTIONS MARKET, BY DIAGNOSIS- MARKET ANALYSIS, 2019 - 2032

  • Maternal Test
  • Neonatal Test
  • Others

GLOBAL PERINATAL INFECTIONS MARKET, BY TREATMENT- MARKET ANALYSIS, 2019 - 2032

  • Antibiotics
  • Antiviral
  • Antiretroviral
  • Others

GLOBAL PERINATAL INFECTIONS MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032

  • Oral
  • Parenteral
  • Others

GLOBAL PERINATAL INFECTIONS MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

GLOBAL PERINATAL INFECTIONS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Perinatal Infections Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Perinatal Infections Market Snippet by Infection
    • 2.1.2. Perinatal Infections Market Snippet by Diagnosis
    • 2.1.3. Perinatal Infections Market Snippet by Treatment
    • 2.1.4. Perinatal Infections Market Snippet by Route of Administration
    • 2.1.5. Perinatal Infections Market Snippet by End User
    • 2.1.6. Perinatal Infections Market Snippet by Country
    • 2.1.7. Perinatal Infections Market Snippet by Region
  • 2.2. Competitive Insights

3. Perinatal Infections Key Market Trends

  • 3.1. Perinatal Infections Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Perinatal Infections Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Perinatal Infections Market Opportunities
  • 3.4. Perinatal Infections Market Future Trends

4. Perinatal Infections Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Perinatal Infections Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Perinatal Infections Market Landscape

  • 6.1. Perinatal Infections Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Perinatal Infections Market - By Infection

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Infection, 2023 & 2032 (%)
    • 7.1.2. Cytomegalovirus Infection
    • 7.1.3. Enterovirus Infection
    • 7.1.4. Genital Herpes
    • 7.1.5. Gonorrhoea
    • 7.1.6. Human Immunodeficiency Virus
    • 7.1.7. Others

8. Perinatal Infections Market - By Diagnosis

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Diagnosis, 2023 & 2032 (%)
    • 8.1.2. Maternal Test
    • 8.1.3. Neonatal Test
    • 8.1.4. Others

9. Perinatal Infections Market - By Treatment

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Treatment, 2023 & 2032 (%)
    • 9.1.2. Antibiotics
    • 9.1.3. Antiviral
    • 9.1.4. Antiretroviral
    • 9.1.5. Others

10. Perinatal Infections Market - By Route of Administration

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Route of Administration, 2023 & 2032 (%)
    • 10.1.2. Oral
    • 10.1.3. Parenteral
    • 10.1.4. Others

11. Perinatal Infections Market - By End User

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 11.1.2. Hospitals
    • 11.1.3. Homecare
    • 11.1.4. Specialty Clinics
    • 11.1.5. Others

12. Perinatal Infections Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Perinatal Infections Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Perinatal Infections Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.10. Italy
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.10.3. Italy Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
      • 12.3.10.4. Italy Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.3.10.5. Italy Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.3.10.6. Italy Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.10.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.11. United Kingdom
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.11.3. United Kingdom Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
      • 12.3.11.4. United Kingdom Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.3.11.5. United Kingdom Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.3.11.6. United Kingdom Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.11.7. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.12. France
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.12.3. France Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
      • 12.3.12.4. France Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.3.12.5. France Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.3.12.6. France Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.12.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.13. Russia
      • 12.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.13.2. Russia Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
      • 12.3.13.3. Russia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.3.13.4. Russia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.3.13.5. Russia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.13.6. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.14. Netherlands
      • 12.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.14.2. Netherlands Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
      • 12.3.14.3. Netherlands Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.3.14.4. Netherlands Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.3.14.5. Netherlands Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.14.6. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.15.2. Sweden Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.16. Poland
      • 12.3.16.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.16.2. Poland Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
      • 12.3.16.3. Poland Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.3.16.4. Poland Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.3.16.5. Poland Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.16.6. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.17. Rest of Europe
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.17.3. Rest of the Europe Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
      • 12.3.17.4. Rest of the Europe Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.3.17.5. Rest of the Europe Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.3.17.6. Rest of the Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.17.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Perinatal Infections Key Manufacturers in Asia Pacific
    • 12.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.4.4. Asia Pacific Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
    • 12.4.5. Asia Pacific Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 12.4.6. Asia Pacific Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 12.4.7. Asia Pacific Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 12.4.8. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.9. India
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.9.3. India Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
      • 12.4.9.4. India Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.4.9.5. India Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.4.9.6. India Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.9.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.10. China
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.10.3. China Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
      • 12.4.10.4. China Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.4.10.5. China Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.4.10.6. China Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.10.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.14. Thailand
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.14.3. Thailand Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
      • 12.4.14.4. Thailand Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.4.14.5. Thailand Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.4.14.6. Thailand Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.14.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.15. Indonesia
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.15.3. Indonesia Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
      • 12.4.15.4. Indonesia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.4.15.5. Indonesia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.4.15.6. Indonesia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.15.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.5. Latin America
    • 12.5.1. Overview
    • 12.5.2. Perinatal Infections Key Manufacturers in Latin America
    • 12.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.5.4. Latin America Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
    • 12.5.5. Latin America Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 12.5.6. Latin America Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 12.5.7. Latin America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 12.5.8. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Perinatal Infections Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Perinatal Infections Industry

  • 13.1. Competitive Dashboard
  • 13.2. Company Profiles
    • 13.2.1. Merck KgaA
    • 13.2.2. Beckman Coulter Inc.
    • 13.2.3. BIOMERIEUX
    • 13.2.4. Bio-Rad Laboratories, Inc
    • 13.2.5. Danaher
    • 13.2.6. Hologic Inc.
    • 13.2.7. Gilead Sciences, Inc.
    • 13.2.8. Emcure Pharmaceuticals Limited.
    • 13.2.9. Cipla Inc.
    • 13.2.10. Hetero
    • 13.2.11. Bausch Health Companies Inc.
    • 13.2.12. Johnson & Johnson Private Limited
    • 13.2.13. Mylan N.V.
    • 13.2.14. Teva Pharmaceutical Industries Ltd.
    • 13.2.15. Sanofi
    • 13.2.16. Novartis AG
    • 13.2.17. Sun Pharmaceutical Industries Ltd
    • 13.2.18. Others

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us